Clinical Trial Update: Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cetuximab with carboplatin, paclitaxel, and radiotherapy for advanced locoregional head and neck squamous cell carcinomas (GCC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Cetuximab (Erbitux) (Cetuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Cancer of Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2014-04-09